Company Number: 13015727

Analysis Date: 2025-07-20 14:40 UTC

Financial Health Assessment for RIAMAY LIMITED

---

1. Financial Health Score:

Grade: D – The company is currently dormant with minimal financial activity, which limits its operational and financial vitality. While dormancy implies an absence of distress symptoms, the lack of active financial transactions and negligible assets signal a very low level of business activity and financial robustness.

---

2. Key Vital Signs:

Metric	Value	Interpretation
Status	Active	The company is legally operational and not under liquidation or administration.
Account Category	Dormant	No significant trading or financial transactions during the reported period.
Cash at Bank	£1	Minimal cash balance, indicating no operational cash flow or liquidity.
Net Assets	£1	Net assets equal to nominal share capital only, reflecting no accumulated profit or reserves.
Share Capital	£1	Nominal capital, typical for a dormant company with minimal financial activity.
Director and PSC	Single Director/PSC	Control concentrated in one individual with full ownership and control rights.
Filing Compliance	Up to date	All filings including accounts and confirmation statements are current and not overdue.
Industry Classification	Dispensing Chemist	Company registered as a dispensing chemist, but no active trading is reported.

---

3. Diagnosis:

The company exhibits the classic signs of a dormant entity—minimal financial activity, essentially no cash flow, and net assets limited to the nominal share capital. There are no symptoms of financial distress such as liabilities, losses, or negative equity since no trading has occurred. However, the absence of active business operations means the company is not generating revenue or profits, which could be a symptom of business inertia or strategic pause.

The control structure is concentrated in a single individual who holds full ownership and voting rights, implying straightforward governance but potential risk of single-person dependency. The company's filings are timely and compliant, indicating good administrative health and regulatory adherence.

---

4. Recommendations:

• Assess Strategic Intent: Clarify whether the company is intended to remain dormant as a holding or shell entity, or if reactivation and trading are planned. A dormant status is sustainable short-term but not a substitute for active financial growth.

• Capital and Activity Review: If the company seeks to commence trading, inject working capital and prepare for operational expenses. Establish a budget and cash flow forecast to monitor financial health proactively.

• Governance Check: Consider appointing additional directors or officers to diversify management and spread fiduciary responsibilities, especially if business activity is to increase.

• Maintain Compliance: Continue timely submission of dormant accounts to avoid penalties and maintain good standing with Companies House.

• Risk Management: Monitor any changes in regulatory requirements for dormant companies and prepare to transition accounts and audits if trading commences.

---

Medical Analogy:
RIAMAY LIMITED is akin to a patient in a dormant state—no active symptoms of disease (financial distress) but also no pulse of economic activity (cash flow or revenue). The company is "asleep," with vital signs stable but weak, requiring a plan to "wake" and strengthen its financial health.

---